Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Journey Medical Corporation (DERM) vs Sofgen Pharma S.A (PROCF)

Journey Medical Corporation and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. Journey Medical Corporation is the larger, with a market value of $178.4M against $114.0M — 1.6× the size. Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against 5.10%. Sofgen Pharma S.A has the higher net margin (9.52% vs −8.95%) and the higher return on invested capital (15.2% vs −5.89%). Across the 17 metrics below, Sofgen Pharma S.A leads on 11 and Journey Medical Corporation on 6.

Valuation

Metric DERM PROCF Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.48 n/m 2.25
P/B 5.26 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA 96.75 3.29 12.29
EV/Sales 2.47 0.70 2.56
Earnings yield (3.58%) 0.00% (2.99%)
Free cash flow yield (13.32%) 0.00% 0.00%

Profitability

Metric DERM PROCF Drug Manufacturers Specialty & Generic median
Gross margin 65.45% 56.16% 53.94%
Operating margin (4.41%) 17.01% 0.00%
Net margin (8.95%) 9.52% 0.00%
Free cash flow margin (10.99%) 17.66% 0.00%
Return on equity (23.77%) (213.06%) (0.40%)
Return on assets (6.80%) 8.82% (3.32%)
Return on invested capital (5.89%) 15.21% 0.00%

Growth

Metric DERM PROCF Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 20.89% 5.10% 10.01%
EPS growth (last fiscal year) 34.72% (270.30%) —
Revenue growth, 5-year CAGR 6.79% (1.82%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DERM PROCF Drug Manufacturers Specialty & Generic median
Debt to equity 0.79 (435.78) 0.05
Current ratio 1.59 0.64 2.31
Net debt to EBITDA (0.35) (7.21) 0.85

Dividend

Metric DERM PROCF Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric DERM PROCF Drug Manufacturers Specialty & Generic median
Market cap 178.38m 113.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack